Resources
Share recent publications on regulatory trends, FDA programs, and oncology clinical trial
strategies, such as articles by MediRama's team on oncology drug development.
Total 113
View More
MediRama published a paper in TCP Analyzing FDA Review Documents for Approved ADCs
- 2026.01.15
- Souce: THE BIO
.jpg)
View More
MediRama and the Korea Drug Research Association Successfully Conclude ‘Oncology Drug Development Strategy Training’
- 2025.10.22
- Souce: THE BIO
View More
BIX 2025: What ‘radical’ changes in US, China mean for bio sector
- 2025.10.22
- Souce: BioWorld
.jpg)
View More
[GCCL Special Contribution ②] The Significance of the FDA’s Oncology Expedited Review System and Its Strategic Utilization
- 2025.09.23
- Souce: THE BIO
.jpg)
View More
[GCCL Special Contribution ①] The Significance of the FDA’s Oncology Expedited Programs and Their Strategic Utilization
- 2025.09.19
- Souce: THE BIO
.jpg)
View More
NEORNAT-Medirama MOUs New Drug Development and Clinical Cooperation
- 2025.07.31
- Souce: HITNEWS
.png)